Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects
Status:
NOT_YET_RECRUITING
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind, placebo-controlled, parallel-group clinical trial. To preliminarily evaluate the safety and efficacy of KHN702 tablets in moderate to severe post-operative pain patients.